Literature DB >> 2596574

Pathologic findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations.

H Ratech1, R Hirschhorn, M A Greco.   

Abstract

Eight autopsies of patients with adenosine deaminase deficient-severe combined immunodeficiency disease (ADA-SCID) were reviewed with special emphasis on the lymphoid tissues. The thymus histology in five cases was remarkably uniform, whether or not prior ADA enzyme replacement or immunologic reconstitution therapy had been administered. Lymph nodes and spleens in all cases examined showed a residual nonlymphoid architectural framework corresponding to usual T and B cell zones found in normals. The development of an extranodal, monoclonal IgA lambda B cell immunoblastic lymphoma as a terminal event in one patient after several years of successful ADA enzyme replacement therapy through multiple red blood cell transfusions is described. In another patient with long-term ADA enzyme replacement, a terminal autoimmune hemolytic anemia developed. Autopsy revealed severe deposits of iron in the B cell zones of the lymph nodes, which is an unusual location. In addition, iron deposits outlined the splenic trabeculae, as well as the ring fibers and bridging fibers of the splenic sinuses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2596574      PMCID: PMC1880483     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

Review 1.  Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

Authors:  D W Hanto; G Frizzera; K J Gajl-Peczalska; R L Simmons
Journal:  Transplantation       Date:  1985-05       Impact factor: 4.939

2.  Lymphoma in a patient with severe combined immunodeficiency with adenosine deaminase deficiency, following unsustained engraftment of histoincompatible T cell-depleted bone marrow.

Authors:  N Kapoor; L K Jung; D Engelhard; J Filler; I Shalit; K S Landreth; R A Good
Journal:  J Pediatr       Date:  1986-03       Impact factor: 4.406

3.  Effects of deoxycoformycin in mice. I. Suppression and enhancement of in vivo antibody responses to thymus-dependent and -independent antigens.

Authors:  H Ratech; M K Bell; R Hirschhorn; G J Thorbecke
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

4.  Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency.

Authors:  W T Shearer; J Ritz; M J Finegold; I C Guerra; H M Rosenblatt; D E Lewis; M S Pollack; L H Taber; C V Sumaya; F C Grumet
Journal:  N Engl J Med       Date:  1985-05-02       Impact factor: 91.245

5.  Individual tumors of multifocal EB virus-induced malignant lymphomas in tamarins arise from different B-cell clones.

Authors:  M L Cleary; M A Epstein; S Finerty; R F Dorfman; G W Bornkamm; J K Kirkwood; A J Morgan; J Sklar
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

6.  Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.

Authors:  H Ratech; M A Greco; G Gallo; D L Rimoin; H Kamino; R Hirschhorn
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

7.  Prenatal diagnosis of three cases of severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency.

Authors:  D C Linch; R J Levinsky; C H Rodeck; K A Maclennan; H A Simmonds
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

8.  Malignant lymphoma in the X-linked lymphoproliferative syndrome.

Authors:  D S Harrington; D D Weisenburger; D T Purtilo
Journal:  Cancer       Date:  1987-04-15       Impact factor: 6.860

9.  Malignant lymphoma of mucosa-associated lymphoid tissue.

Authors:  P G Isaacson; J Spencer
Journal:  Histopathology       Date:  1987-05       Impact factor: 5.087

10.  Primary lymphomas of the small intestine: east-west contrast.

Authors:  H Al-Mondhiry
Journal:  Am J Hematol       Date:  1986-05       Impact factor: 10.047

View more
  9 in total

1.  Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome.

Authors:  Olga Nikolajeva; Austen Worth; Rosie Hague; Nuria Martinez-Alier; Joanne Smart; Stuart Adams; E Graham Davies; H Bobby Gaspar
Journal:  J Clin Immunol       Date:  2015-04-15       Impact factor: 8.317

Review 2.  Lymphoproliferation in Inborn Errors of Immunity: The Eye Does Not See What the Mind Does Not Know.

Authors:  Saniya Sharma; Rakesh Kumar Pilania; Gummadi Anjani; Murugan Sudhakar; Kanika Arora; Rahul Tyagi; Manpreet Dhaliwal; Pandiarajan Vignesh; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

3.  Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency.

Authors:  L D Notarangelo; G Stoppoloni; R Toraldo; E Mazzolari; A Coletta; P Airò; C Bordignon; A G Ugazio
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

4.  Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice.

Authors:  M Wakamiya; M R Blackburn; R Jurecic; M J McArthur; R S Geske; J Cartwright; K Mitani; S Vaishnav; J W Belmont; R E Kellems
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

5.  Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.

Authors:  Aisha Vanessa Sauer; Immacolata Brigida; Nicola Carriglio; Alessandro Aiuti
Journal:  Front Immunol       Date:  2012-08-27       Impact factor: 7.561

Review 6.  Lymph node pathology in primary combined immunodeficiency diseases.

Authors:  F Facchetti; L Blanzuoli; M Ungari; O Alebardi; W Vermi
Journal:  Springer Semin Immunopathol       Date:  1998

7.  Heterozygous Mutation in Adenosine Deaminase Gene in a Patient With Severe Lymphopenia Following Corticosteroid Treatment of Autoimmune Hemolytic Anemia.

Authors:  Serena I Tripodi; Paola Corti; Silvia Giliani; Arnalda Lanfranchi; Andrea Biondi; Raffaele Badolato
Journal:  Front Pediatr       Date:  2018-10-01       Impact factor: 3.418

Review 8.  First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.

Authors:  Maddalena Migliavacca; Andrea Assanelli; Maurilio Ponzoni; Roberta Pajno; Federica Barzaghi; Fabio Giglio; Francesca Ferrua; Marta Frittoli; Immacolata Brigida; Francesca Dionisio; Roberto Nicoletti; Miriam Casiraghi; Maria Grazia Roncarolo; Claudio Doglioni; Jacopo Peccatori; Fabio Ciceri; Maria Pia Cicalese; Alessandro Aiuti
Journal:  Front Immunol       Date:  2018-02-02       Impact factor: 7.561

9.  A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity).

Authors:  Irbaz Bin Riaz; Warda Faridi; Mrinal M Patnaik; Roshini S Abraham
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.